Oxford Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Oxford Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-269	Closed	-$31K	–	2024
2019 Q2	$31K	Buy	+269	New	+$42.6K	﹤0.01%	1649
2017 Q3	–	Sell	-116	Closed	-$18K	–	1764
2017 Q2	$18K	Buy	+116	New	+$23.5K	﹤0.01%	1438
2016 Q1	–	Sell	-160	Closed	-$166K	–	934
2015 Q4	$166K	Buy	+160	New	+$158K	﹤0.01%	811
2015 Q2	–	Sell	-99	Closed	-$223K	–	761
2015 Q1	$223K	Buy	+99	New	+$169K	0.01%	602
2014 Q2	–	Sell	-34	Closed	-$65K	–	803
2014 Q1	$65K	Buy	+34	New	+$80.4K	﹤0.01%	627

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Oxford Asset Management's AMPE Position: Q3 2019 in Review

Oxford Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2019, closing a stake of 269 shares — an estimated $31K sold.

Oxford Asset Management first reported a position in AMPE in Q1 2014 and held it in 5 quarters. The position peaked at $223K in Q1 2015. 75 funds tracked by Wall St. Rank hold AMPE as of Q3 2019.

Oxford Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 269 Ampio Pharmaceuticals Inc. shares in Q3 2019, an estimated $31K.
Oxford Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 5 quarters.
Oxford Asset Management's Ampio Pharmaceuticals Inc. position peaked at $223K in Q1 2015.
75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.